Cargando…
Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia
Acquired aplastic anemia (AA) is a type of bone marrow failure (BMF) syndrome characterized by partial or total bone marrow (BM) destruction resulting in peripheral blood (PB) pancytopenia, which is the reduction in the number of red blood cells (RBC) and white blood cells (WBC), as well as platelet...
Autores principales: | Gonzaga, Vivian Fonseca, Wenceslau, Cristiane Valverde, Lisboa, Gustavo Sabino, Frare, Eduardo Osório, Kerkis, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733198/ https://www.ncbi.nlm.nih.gov/pubmed/29333168 http://dx.doi.org/10.1155/2017/8076529 |
Ejemplares similares
-
Therapeutic Potential of Human Immature Dental Pulp Stem Cells Observed in Mouse Model for Acquired Aplastic Anemia
por: Gonzaga, Vivian Fonseca, et al.
Publicado: (2022) -
Neural and mesenchymal stem cells in animal models of Huntington’s disease: past experiences and future challenges
por: Kerkis, Irina, et al.
Publicado: (2015) -
Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment
por: Medinger, Michael, et al.
Publicado: (2018) -
Cell-based technologies for Huntington’s disease
por: Haddad, Mônica Santoro, et al.
Publicado: (2016) -
Enhanced Adipogenicity of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia
por: Tripathy, Naresh Kumar, et al.
Publicado: (2014)